Atezolizumab in Combination With Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients With Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Atezolizumab (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Adverse reactions
- Acronyms AdORN
- 09 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 May 2018.
- 01 Mar 2018 Planned initiation date changed from 1 Jan 2018 to 3 mar 2018.
- 11 Jan 2018 New trial record